0.5017
price down icon5.38%   -0.0285
 
loading
前日終値:
$0.5302
開ける:
$0.5273
24時間の取引高:
639.49K
Relative Volume:
1.21
時価総額:
$46.53M
収益:
$2.24M
当期純損益:
$-136.67M
株価収益率:
-0.2191
EPS:
-2.29
ネットキャッシュフロー:
$-102.08M
1週間 パフォーマンス:
-7.72%
1か月 パフォーマンス:
-9.57%
6か月 パフォーマンス:
-63.91%
1年 パフォーマンス:
-84.07%
1日の値動き範囲:
Value
$0.498
$0.5273
1週間の範囲:
Value
$0.498
$0.57
52週間の値動き範囲:
Value
$0.3418
$3.70

Century Therapeutics Inc Stock (IPSC) Company Profile

Name
名前
Century Therapeutics Inc
Name
セクター
Healthcare (1154)
Name
電話
215-981-4000
Name
住所
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Name
職員
165
Name
Twitter
Name
次回の収益日
2025-03-19
Name
最新のSEC提出書
Name
IPSC's Discussions on Twitter

IPSC を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IPSC
Century Therapeutics Inc
0.5017 46.53M 2.24M -136.67M -102.08M -2.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-08 開始されました Rodman & Renshaw Buy
2023-08-28 ダウングレード JP Morgan Overweight → Neutral
2022-12-27 開始されました Chardan Capital Markets Buy
2022-10-31 開始されました Guggenheim Buy
2022-10-10 開始されました Canaccord Genuity Buy
2022-05-23 開始されました H.C. Wainwright Buy
2022-05-12 開始されました William Blair Mkt Perform
2021-07-13 開始されました BofA Securities Buy
2021-07-13 開始されました JP Morgan Overweight
2021-07-13 開始されました Piper Sandler Overweight
すべてを表示

Century Therapeutics Inc (IPSC) 最新ニュース

pulisher
Apr 24, 2025

Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com

Apr 24, 2025
pulisher
Apr 24, 2025

Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK

Apr 24, 2025
pulisher
Apr 23, 2025

Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com

Apr 23, 2025
pulisher
Apr 20, 2025

Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN

Apr 20, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Purchased by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

American Century Companies Inc. Buys 24,090 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

HC Wainwright Issues Positive Forecast for IPSC Earnings - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Acquires 39,932 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - Defense World

Apr 07, 2025
pulisher
Apr 07, 2025

American Century Companies Inc. Has $3.36 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM) - Defense World

Apr 07, 2025
pulisher
Apr 06, 2025

American Century Companies Inc. Buys 1,622 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Apr 06, 2025
pulisher
Apr 05, 2025

Century Therapeutics Partners with Experts for New Trial on Autoimmune Diseases - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

American Century Companies Inc. Purchases 31,251 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

HC Wainwright Issues Pessimistic Forecast for Century Therapeutics (NASDAQ:IPSC) Stock Price - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

H.C. Wainwright cuts Century Therapeutics target to $2 By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Shares Sold by American Century Companies Inc. - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

American Century Companies Inc. Raises Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by American Century Companies Inc. - Defense World

Apr 02, 2025
pulisher
Mar 30, 2025

Guggenheim Reiterates Buy Rating for Century Therapeutics (NASDAQ:IPSC) - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

What is Chardan Capital’s Estimate for IPSC FY2025 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Century Therapeutics (NASDAQ:IPSC) Price Target Lowered to $7.00 at Chardan Capital - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

William Blair Issues Optimistic Forecast for IPSC Earnings - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Mar 24, 2025
pulisher
Mar 24, 2025

Q1 EPS Estimate for Century Therapeutics Boosted by Analyst - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Chardan Cuts Price Target on Century Therapeutics to $7 From $11, Keeps Buy Rating - MarketScreener

Mar 24, 2025
pulisher
Mar 23, 2025

Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Guggenheim Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $5.00 - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Piper Sandler Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00 - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Guggenheim cuts Century Therapeutics target to $5, keeps Buy rating By Investing.com - Investing.com Canada

Mar 22, 2025
pulisher
Mar 22, 2025

What is William Blair’s Estimate for IPSC Q3 Earnings? - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Demystifying Century Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Century Therapeutics Reports 2024 Financial Results and Strategic Updates - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Leerink Partners Adjusts Price Target on Century Therapeutics to $8 From $13, Keeps Outperform Rating - Marketscreener.com

Mar 20, 2025

Century Therapeutics Inc (IPSC) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Century Therapeutics Inc (IPSC) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Russotti Gregory
See Remarks
Mar 10 '25
Sale
0.61
2,360
1,451
272,573
Farid Adrienne
Chief Operations Officer
Mar 10 '25
Sale
0.61
2,359
1,451
131,717
Carr Douglas
SVP Finance & Operations
Mar 10 '25
Sale
0.61
1,240
763
315,556
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):